StreetInsider.com News Articles

Seegnal Inc. Announces Conclusion of Services Agreement

Tue, 22 Sep 2026 07:30:00 -0400

Calgary, Alberta, Sept. 22, 2026 (GLOBE NEWSWIRE) -- Seegnal Inc. (TSXV:SEGN) (“Seegnal” or the “Company”), today announced that its investor relations technologies and services agreement dated March 26, 2026 (“Services Agreement”) with CapitaLynx Ltd. will conclude effective September 26, 2026.

The Services Agreement was previously disclosed in the Company’s news release dated April 1, 2026. During the engagement, the Company rebuilt its investor materials, narrative positioning and investor portal and upgraded its core investor relations assets. The Company intends to continue to use those materials, infrastructure and technologies. The Company wishes to thank CapitaLynx for its

Seegnal Inc. Announces Conclusion of Services Agreement

Tue, 22 Sep 2026 07:30:00 -0400

Seegnal Reports Second Quarter 2026 Financial Results and Provides Business Update

Tue, 01 Sep 2026 08:30:00 -0400

Expanded Israeli Hospital Footprint with Five-Year Deployment at Nazareth Hospital EMMS

Second Quarter Revenue Increased 15% to $351,000 and First Half Revenue Increased 16% to $706,000

CALGARY, Alberta, Sept. 01, 2026 (GLOBE NEWSWIRE) -- Seegnal Inc. (TSXV: SEGN) (“Seegnal” or the “Company”), a developer of innovative healthcare technology focused on mitigating medication risks, today reported financial results for the three and six months ended June 30, 2026, and provided a corporate update.

Recent Business Highlights

Graduated from AARP Accelerator: In August 2026, Seegnal completed the eight-week Summer 2026 cohort

Seegnal Reports Second Quarter 2026 Financial Results and Provides Business Update

Tue, 01 Sep 2026 08:30:00 -0400

Expanded Israeli Hospital Footprint with Five-Year Deployment at Nazareth Hospital EMMS

Second Quarter Revenue Increased 15% to $351,000 and First Half Revenue Increased 16% to $706,000

Recent Business Highlights

Graduated from AARP Accelerator: In August 2026, Seegnal completed the eight-week Summer 2026 cohort

Seegnal Announces Listing on the Frankfurt Stock Exchange

Fri, 10 Jul 2026 09:14:00 -0400

CALGARY, AB, July 10, 2026 (GLOBE NEWSWIRE) -- Seegnal Inc. (TSXV: SEGN) ("Seegnal" or the "Company"), a developer of innovative healthcare technology focused on mitigating medication risks, today announced that its common shares will commence trading on the Frankfurt Stock Exchange (Frankfurter Wertpapierbörse, "FSE") today, July 10, 2026, under the ticker symbol "2I1” (WKN: A41FV7).

The Company's common shares will continue to trade on the TSX Venture Exchange under the symbol "SEGN" (ISIN: CA81573E1060).

The Frankfurt Stock Exchange is one of the world's largest and most established trading venues by market capitalization and is operated by

Seegnal Announces Listing on the Frankfurt Stock Exchange

Fri, 10 Jul 2026 09:14:00 -0400

The Company's common shares will continue to trade on the TSX Venture Exchange under the symbol "SEGN" (ISIN: CA81573E1060).

The Frankfurt Stock Exchange is one of the world's largest and most established trading venues by market capitalization and is operated by

Seegnal Announces Listing on the Frankfurt Stock Exchange

Fri, 10 Jul 2026 09:14:00 -0400

The Company's common shares will continue to trade on the TSX Venture Exchange under the symbol "SEGN" (ISIN: CA81573E1060).

The Frankfurt Stock Exchange is one of the world's largest and most established trading venues by market capitalization and is operated by

Seegnal Announces Listing on the Frankfurt Stock Exchange

Fri, 10 Jul 2026 09:14:00 -0400

The Company's common shares will continue to trade on the TSX Venture Exchange under the symbol "SEGN" (ISIN: CA81573E1060).

The Frankfurt Stock Exchange is one of the world's largest and most established trading venues by market capitalization and is operated by

Seegnal Announces Listing on the Frankfurt Stock Exchange

Fri, 10 Jul 2026 09:14:00 -0400

The Company's common shares will continue to trade on the TSX Venture Exchange under the symbol "SEGN" (ISIN: CA81573E1060).

The Frankfurt Stock Exchange is one of the world's largest and most established trading venues by market capitalization and is operated by

Seegnal Announces Listing on the Frankfurt Stock Exchange

Fri, 10 Jul 2026 09:14:00 -0400

The Company's common shares will continue to trade on the TSX Venture Exchange under the symbol "SEGN" (ISIN: CA81573E1060).

The Frankfurt Stock Exchange is one of the world's largest and most established trading venues by market capitalization and is operated by

Seegnal Announces Listing on the Frankfurt Stock Exchange

Fri, 10 Jul 2026 09:14:00 -0400

The Company's common shares will continue to trade on the TSX Venture Exchange under the symbol "SEGN" (ISIN: CA81573E1060).

The Frankfurt Stock Exchange is one of the world's largest and most established trading venues by market capitalization and is operated by

Seegnal Announces Listing on the Frankfurt Stock Exchange

Fri, 10 Jul 2026 09:14:00 -0400

The Company's common shares will continue to trade on the TSX Venture Exchange under the symbol "SEGN" (ISIN: CA81573E1060).

The Frankfurt Stock Exchange is one of the world's largest and most established trading venues by market capitalization and is operated by

Seegnal to Deploy its Medication Safety Platform Across Nazareth Hospital EMMS, Expanding its Israeli Hospital Footprint

Thu, 25 Jun 2026 08:30:00 -0400

CALGARY, AB, June 25, 2026 (GLOBE NEWSWIRE) -- Seegnal Inc. (TSXV: SEGN) (“Seegnal” or the “Company”), a developer of innovative healthcare technology focused on mitigating medication risks, today announced that its Israeli operating subsidiary, Seegnal eHealth Ltd., has signed an agreement (the “Agreement”) to deploy Seegnal’s clinical decision support platform across Nazareth Hospital EMMS (“Nazareth Hospital” or the “Hospital”), one of the oldest hospitals in northern Israel that has served the Galilee for more than 160 years.